Maine LD180 prohibits health insurance carriers and pharmacy benefits managers from discriminatory practices against 340B drug pricing participants.
Maine LD180 aims to protect entities participating in the federal 340B drug pricing program and their pharmacy providers from discriminatory practices by health insurance carriers and pharmacy benefits managers. The bill prohibits these entities from preventing or interfering with a covered person's choice to use any pharmacy provider without penalty. It also mandates that reimbursements for prescription drugs or pharmacy services must be at least the national average drug acquisition cost at the time the drug is administered or dispensed, plus a dispensing fee.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.